High Cortisol Concentration Without Cushingoid Appearance

Published:November 06, 2022DOI:
      A 53-year-old man was referred to us for evaluating left adrenal incidentaloma. His morning plasma adrenocorticotropic hormone (ACTH) and serum cortisol levels were 42.5 pg/mL and 30.2 μg/dL, respectively, indicating ACTH-dependent hypercortisolemia. The patient did not exhibit any Cushingoid features, but had mild gynecomastia (Figure). His serum prolactin (PRL) levels were slightly elevated (19.1 ng/mL), whereas estrogen levels were not (9 pg/mL). His testosterone levels were within the normal range (3.40 ng/mL). The 1-mg overnight dexamethasone suppression test did not suppress serum cortisol levels (6.0 μg/dL), despite reducing ACTH levels (1.9 pg/mL). His late-night plasma ACTH and serum cortisol levels were 5.7 pg/mL and 8.0 µg/dL, respectively, indicating autonomous cortisol secretion. However, urinary free cortisol levels were 45.6 μg/day (reference range: 11.2-80.3), suggesting no cortisol over-secretion. Although the serum cortisol levels were high on multiple occasions, his serum electrolytes and white blood cell fractions were within normal limits. No overt metabolic abnormalities were observed. All other hormone levels were within normal ranges.
      FigureThe patient with hypercortisolemia does not exhibit cushingoid features, but rather mild gynecomastia. (A) Front view; (B) side view.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hembree WC
        • Cohen-Kettenis PT
        • Gooren L
        • et al.
        Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline.
        J Clin Endocrinol Metab. 2017; 102: 3869-3903
        • Brien TG
        Human corticosteroid binding globulin.
        Clin Endocrinol (Oxf). 1981; 14: 193-212
        • Murai I
        • Ben-Jonathan N
        Acute stimulation of prolactin release by estradiol: mediation by the posterior pituitary.
        Endocrinology. 1990; 126: 3179-3184
        • Murad MH
        • Elamin MB
        • Garcia MZ
        • et al.
        Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes.
        Clin Endocrinol (Oxf). 2010; 72: 214-231